TP53 and cancer: For KEGG pathway enrichment analysis, these LINC01235-related hub target mRNAs were significantly enriched in cAMP signaling pathway, PID E2F pathway, p53 signaling pathway, and proteoglycans in cancer (Figure 5A, CC, MF, and BP).